Xarelto and Eliquis Kentucky Lawsuits
Xarelto, a drug manufactured by Bayer and is sold by Janssen, a subsidiary of Johnson & Johnson, is a blood thinner prescribed to people for the prevention of stroke in patients with Atrial Fibrillation. It is the second most prescribed drug for atrial fibrillation. Xarelto also treats and prevents Deep Vein Thromobosis (DVT) and pulmonary embolism (PE). Eliquis, also known as apixaban, is a blood thinner that works in a similar fashion to Xarelto. The chief problem with Xarelto and Eliquis is the risk of severe internal bleeding which can result in serious harm or death to Xarelto and Eliquis users.
What are Xarelto and Eliquis?
Xarelto and Eliquis are anticoagulants, which means they are agents which reduce the ability of the blood to clot. Patients who have an irregular heartbeat, or non-valvular atrial fibrillation, have a high risk of developing blood clots which can lead to strokes. The first anticoagulant on the market was Counadin (Warfarin). The problems with Coumadin are that it requires patients to have weekly medical exams, requires dietary restrictions and carries risks of internal bleeding and brain hemorrhaging. The drug Xarelto was introduced in 2011 and was marketed as a better alternative to Coumadin because it did not require weekly doctor monitoring and it carried fewer risks of internal bleeding. Bristol Myers Squibb and Pfizer jointly introduced Eliquis in 2014.
What are the Warning Signs of a Xarelto or Eliquis Causing Internal Bleeding?
Patients who are using Xarelto or Eliquis should be aware of potential symptoms of internal bleeding which can include:
- Rectal bleeding
- Unusual bruising
- Bleeding gums
- Weakness or swelling in extremities
- Vision changes
- Red or black tarry stool
Of course if you are experiencing any of these symptoms you should contact your doctor immediately. The label of Xarelto warns users to not stop taking Xarelto, so you will need a doctor to advise you as to how to best proceed with your medical care. Serious internal bleeding episodes have been experienced by patients who have just begun taking Xarelto. Other cases have occurred after weeks or months of use.
Eliquis and Xarelto Do Not Have a Reversal Agent
An additional weighty issue is that if patients who are using Xarelto or Eliquis experience internal bleeding or hemorrhaging there may not be good treatment alternatives. Xarelto and Eliquis, unlike Coumadin and other anticoagulants, do not have a reversal agent. Antidotes for Coumadin do not work for Xarelto and Eliquis. Therefore, if a patient suffers a serious bleeding event while using Xarelto or Eliquis, it may be irreversible and doctors may not be able to stop the bleeding.
Do Eliquis and Xarelto Patients in Kentucky have a Potential Claim?
Recently Boehringer Ingelheim, which sells a drug very similar to Xarelto and Eliquis, called Pradaxa, has agreed to settle approximately 4,000 lawsuits for about $650 million for failing to warn of the risks of serious internal bleeding. Studies and data are now emerging that indicate that Xarelto and Eliquis carry many of the same risks as Pradaxa. If you have been prescribed Xarelto or Eliquis and have experienced internal bleeding, please contact Brett H. Oppenheimer, PLLC. Brett Oppenheimer is a Kentucky lawyer, who will help you to investigate your options in pursuing a law suit against the manufacturer of Xarelto or the manufacturer of Eliquis. Brett, a personal injury attorney, can help you determine if you may be entitled to financial compensation for your suffering. You can call Brett at (502) 242-8877.